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Background: Lung function is highly heritable and differs between 
the sexes throughout life. However, little is known about sex-
differential genetic effects on lung function. We aimed to conduct the 
first genome-wide genotype-by-sex interaction study on lung function 
to identify genetic effects that differ between males and females. 
Methods: We tested for interactions between 7,745,864 variants and 
sex on spirometry-based measures of lung function in UK Biobank 
(N=303,612), and sought replication in 75,696 independent individuals 
from the SpiroMeta consortium. 
Results: Five independent single-nucleotide polymorphisms (SNPs) 
showed genome-wide significant (P<5x10-8) interactions with sex on 
lung function, and 21 showed suggestive interactions (P<1x10-6). The 
strongest signal, from rs7697189 (chr4:145436894) on forced 
expiratory volume in 1 second (FEV1) (P=3.15x10-15), was replicated 
(P=0.016) in SpiroMeta. The C allele increased FEV1 more in males 
(untransformed FEV1 β=0.028 [SE 0.0022] litres) than females (β=0.009 
[SE 0.0014] litres), and this effect was not accounted for by differential 
effects on height, smoking or pubertal age. rs7697189 resides 
upstream of the hedgehog-interacting protein (HHIP) gene and was 
previously associated with lung function and HHIP lung expression. 
We found HHIP expression was significantly different between the 
sexes (P=6.90x10-6), but we could not detect sex differential effects of 
rs7697189 on expression. 
Conclusions: We identified a novel genotype-by-sex interaction at a 
putative enhancer region upstream of the HHIP gene. Establishing the 
mechanism by which HHIP SNPs have different effects on lung 
function in males and females will be important for our understanding 
of lung health and diseases in both sexes.
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Introduction
Measures of lung function, including forced expiratory volume 
in 1 second (FEV
1
) and forced vital capacity (FVC), are used 
to determine diagnosis and severity of chronic obstructive 
pulmonary disease (COPD). COPD refers to a group of 
complex lung disorders characterised by irreversible (and usually 
progressive) airway obstruction, and is projected to be the third 
leading cause of death globally in 20201. The major risk factor for 
COPD is smoking, but other environmental and genetic factors 
have been identified.
Physiological lung development and function differ throughout 
life between males and females2. It is known that sex hormones 
can influence these processes but the mechanisms are not well 
understood3,4. The incidence and presentation of lung diseases 
such as COPD also exhibit sexual dimorphism. Traditionally 
viewed as a disease of older males, COPD has been increasing 
in prevalence amongst females over the last two decades. It has 
been reported that females are more vulnerable to environmental 
risk factors for COPD and are over-represented amongst suffer-
ers of early-onset severe COPD5,6. Females are also more likely 
to present with small airway disease whereas males are more 
likely to develop emphysematous phenotype. Moreover, females 
report more frequent and/or severe exacerbations of respira-
tory symptoms than males and higher levels of dyspnoea and 
cough5.
In a recent paper, 279 genetic loci were reported as associated 
with lung function traits, but these only explain a small propor-
tion of the heritability7. One possible source of hidden heritability 
is the interaction between genetic factors and biological sex on 
lung function traits. A genome-wide genotype-by-sex interaction 
study in three studies comprising 6260 COPD cases and 5269 
smoking controls found a putative sex-specific risk factor for 
COPD in the CELSR1 gene, a region not previously implicated 
in COPD or lung function8. However, having sufficient statisti-
cal power to reproducibly detect genotype-by-sex interactions 
requires much larger sample sizes. Statistical power can also be 
enhanced by using quantitative lung function traits as outcomes 
instead of COPD diagnoses, but we are not aware of any genome-
wide genotype-by-sex interaction studies on lung function traits. 
Understanding the role of sex in lung function and COPD will be 
important for developing therapeutics that work for both males 
and females9.
In this study, we tested for an interaction effect of 7,745,864 




/FVC, FVC and PEF in 303,612 
individuals from the UK Biobank resource. We sought repli-
cation of our findings in 75,696 independent individuals from 
the SpiroMeta consortium. To our knowledge this is the first 
genome-wide sex-by-genotype interaction study on lung function 
traits, and the largest sex-by-genotype interaction study to focus 
on COPD-related outcomes.
Results
We tested 7,745,864 genome-wide variants with minor allele 
frequency (MAF) ≥ 0.01 and imputation quality scores ≥ 0.3 
for genotype-by-sex interactions on lung function in 303,612 
unrelated individuals of European ancestry from UK Biobank. 
Five independent signals were identified showing genome-wide 
significant (P<5 x 10-8) interaction with sex on at least one of 




/FVC, FVC, and PEF) with 
a further 21 SNPs showing suggestive significance (P<1 x 10-6) 
(Table 1; Figure S1, Extended data10). The top three genome-wide 
significant signals had been previously reported for association 
with lung function: rs7697189 near the gene encoding hedgehog- 
interacting protein (HHIP) (interaction P = 3.15 x 10-15), 
rs9403386 near the gene encoding Adhesion G Protein-Cou-
pled Receptor G6 (ADGRG6, previously known as GPR126) 
(interaction P = 4.56 x 10-9), and rs162185 downstream of the 
gene encoding transcription factor 21 (TCF21) (interaction 
P = 4.87 x 10-9)11–16. This may, in part, reflect greater power to 
detect interactions with variants with strong main effects on lung 
function. Only rs355079 (interaction P = 8.84 x 10-7) showed 
significant effects in opposite directions in males compared to 
females.
We sought evidence for replication of all 26 signals in up to 
75,696 individuals from 20 cohorts of the SpiroMeta consortium. 
One variant, rs76911399, was excluded because it was poorly 
imputed in SpiroMeta cohorts and had no directly genotyped 
or well-imputed proxies (at r2 threshold 0.8). Of the remaining 
25 signals, 19 exhibited the same direction of interaction effect 
as in UK Biobank. Furthermore, the effect sizes (beta coefficients) 
from the regression analyses of all 25 SNPs in UK Biobank and 
SpiroMeta showed a correlation of 0.51 (Figure S2, Extended 
data10). The SNP with the strongest evidence for interaction 
with sex on lung function in SpiroMeta cohorts was rs7697189 
(near HHIP) (replication interaction P = 0.016) (Table 1, 
Figure 1). The minor (C) allele of rs7697189 had a larger effect 
on lung function in males (β = 0.052 [SE 0.004], P = 2.13 x 10-33) 
compared to females (β = 0.013 [SE 0.003], P = 1.16 x 10-5) 
(Table 1). This SNP resides upstream of the HHIP gene and is 
in linkage disequilibrium with two previously reported lung 
function-associated sentinel SNPs, rs1314164116,17 (r2 = 0.91) 
and rs1311699917 (r2 = 0.56). SNP rs7697189 also showed some 
evidence of interaction with sex on PEF (β = -0.035 (0.005), 
P = 8.78 x 10-12), FEV
1
/FVC (β = -0.028 (0.005), P = 8.98 x 10-8), 
and FVC (β = -0.020 (0.005), P = 8.71 x 10-5) (Table S1, Extended 
data10; Figure 2).
rs7697189 interacts with sex on lung function 
independently of height, smoking and pubertal timing
As SNPs in HHIP are also reported to be associated with height18 
and increased height is associated with increased lung function, 
          Amendments from Version 1
Two minor additions have been made to the discussion in 
response to reviewers’ comments. First, we included standing 
height in our regression models, but have added a note in 
the discussion acknowledging that sitting height and thoracic 
height are more closely related to lung function. We included a 
sensitivity analysis using sitting height, but thoracic height was 
not available. Second, we have added a suggestion that sex-
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Figure 1. Meta-analysis of rs7697189-by-sex interaction effects on lung function in SpiroMeta cohorts. The forest plot shows 
the beta-coefficients (test effects, TE) and standard errors for the interaction between rs7697189 and sex on forced expiratory volume 
in 1 second (FEV1) in 20 cohorts of the SpiroMeta consortium (total N = 75,696). The overall effect size from fixed effects meta-analysis is 
represented by the diamond.
it is possible that rs7697189 has differential effects on lung 
function in males and females through differential effects on 
height. However, the association of rs7697189 with standing 
height was not modified by sex in a combined analysis of UK 
Biobank males and females with a genotype-by-sex interaction 
term (interaction P = 0.806). We also conducted a sensitivity 
analysis showing that the effect of the rs7697189-by-sex 
interaction on FEV
1
 was consistent with the original estimate 
after adjustment for sitting height (β = -0.04 [SE = 0.005], 
P = 1.97 × 10-15).
Amongst the 303,612 UK Biobank participants in this study, the 
proportion of ever-smokers was higher in males (52.8%) than 
females (40.3%) (Table S2). A larger effect of rs7697189 on 
lung function in males compared to females could arise if there 
was an interaction effect with smoking. However, there was no 
interaction between rs7697189 and ever-smoking status on FEV
1
 
in this study (interaction P = 0.63). Pack years data was available 
for 94,750 UK Biobank participants. In sensitivity analyses 
we found a similar rs7697189-by-sex effect size on FEV
1
 when 
adjusted for pack years (β = -0.033 [SE = 0.009], P = 3.50 × 10-4) 
and no interaction between genotype and pack years on FEV
1
 
(interaction P = 0.80).
SNP rs7697189, and correlated SNPs in the region, have been 
shown to be associated with expression levels of HHIP in lung 
tissue19. HHIP is a critical protein during early development 
and HHIP variants have been associated with lung function in 
infancy20. We tested whether HHIP SNPs also have differential 
effects on lung function in females compared to males in 
childhood using data from children with an average age of 
eight years in the ALSPAC and Raine studies (N = 5645). In the 
meta-analysis of ALSPAC and Raine (Figure S3, Extended data10), 
whilst we observed a point estimate for the rs7697189-by-sex 
interaction effect on FEV
1
 that was consistent with the confidence 
intervals for the discovery effect observed in UK Biobank, the 
confidence intervals overlapped the null (which likely reflects 
in part the smaller numbers studied in these cohorts). Finally, as 
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Figure 2. Genotype-by-sex interaction results within the HHIP region for lung function traits in UK Biobank. The SNP with the 
strongest association in the rs7697189-proximal region is represented by a blue diamond. The FEV1 and PEF sentinels are rs7697189, the 
FEV1/FVC sentinel is rs1512281 (R2 = 0.95 with rs7697189), and the FVC sentinel is rs7681384 (R2 = 0.57 with rs7697189). Note that there is an 
independent suggestively significant signal from rs2353939 and surrounding SNPs for FVC, but this did not replicate in SpiroMeta cohorts. 
All other SNVs are colour coded according to their linkage disequilibrium (R2) with the sentinel SNP (as shown in the key). All imputed SNVs 
are plotted irrespective of MAF, demonstrating that rarer variants are not exhibiting significant interactions with sex on lung function. The 
locations of genes in the region are shown in the lower panel of each plot. Recombination rate is represented by the blue lines. These plots 
were generated using LocusZoom software.
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pubertal timing has been associated with adult lung function21, we 
tested for an effect of relative age at puberty on the association 
between rs7697189 and lung function in a sex-stratified analysis. 
The association between HHIP SNPs and lung function was 
adjusted for relative age at voice breaking in males and for age 
at menarche in females, but adjusted effect estimates were highly 
consistent with the unadjusted estimates of the SNPs on lung 
function (Table S3, Extended data10).
rs7697189 is associated with HHIP expression, but no 
interaction with sex
It is possible that rs7697189 interacts with sex on lung function 
through differential effects on HHIP expression. We confirmed 
that rs7697189 is associated with HHIP expression in lung tissue 
but we did not detect an interaction with sex on HHIP expres-
sion (Table S4, Extended data10). However, HHIP (in all samples 
irrespective of genotype at rs7697189) did show differential 
expression between males and females, with females show-
ing higher expression (Table S5; Extended data10). This agrees 
with GTEx data on HHIP lung expression in males and females 
(Figure S4, Extended data10).
rs7697189 is in linkage disequilibrium with a SNP 
predicted to disrupt SREBP and SRF motifs
HaploReg v4.122 was used to identify whether rs7697189, or SNPs 
in linkage disequilibrium, affected transcription factor binding 
motifs. This demonstrated that rs7697189 itself was predicted 
to change FAC1 and FOXO motifs and was within a chromatin 
mark indicative of enhancer activity in embryonic stem cell lines 
differentiated to CD56+ mesoderm and CD184+ endoderm 
cultured cells. A SNP (rs12504628) in complete linkage 
disequilibrium with rs7697189 changes SREBP and SRF motifs. 
These transcription factors have been reported to be involved 
in sex hormone signalling23,24.
Discussion
We identified a genome-wide significant genotype-by-sex inter-
action signal at a locus previously reported for association with 
lung function upstream of the HHIP gene (rs7697189, FEV
1
 
interaction P = 3.15 × 10-15). The SNP showed some evidence 
of replication in 75,696 individuals from 20 independent 
studies of the  SpiroMeta consortium (β = -0.025 (0.01), 
P = 0.016), although it did not pass a Bonferroni correction for 
multiple testing. We demonstrated that the differential effects of 
this SNP in males and females (FEV
1
 β = 0.052 (0.004) in 
males and 0.013 (0.003) in females, corresponding to an 
untransformed FEV
1
 β = 0.028 [SE 0.0022] litres in males vs 
β = 0.009 [SE 0.0014] litres in females) did not appear to be 
mediated by effects on height, smoking behaviour or pubertal age.
There was evidence that SNPs at the HHIP locus demonstrated 
interactions with sex on two additional lung function traits in 
UK Biobank: FEV
1
/FVC and PEF (β = -0.028 (0.005), P = 8.78 
× 10-12 and β = -0.035 (0.005), P = 8.78 × 10-12, respectively). 
Stratified analyses in males and females demonstrated that these 
SNPs appeared to have a stronger effect on lung function in males 
compared to females. There was no interaction between these 
SNPs and ever-smoking status on lung function in UK Biobank, 
suggesting that the stronger effect in males is not due to 
differences in smoking behaviour. We also demonstrate that 
an association between these SNPs and standing height is not 
modified by sex, suggesting that differential effects on height in 
males and females do not explain the genotype-by-sex interac-
tion on lung function.  It should be noted, however, that lung 
function is more closely related to sitting and thoracic height 
than standing height.  We conducted sensitivity analyses showing 
that the rs7697189-by-sex interaction remained after adjustment 
for sitting height, but thoracic height was not available.
In contrast to these results, a recent study found compara-
tively weak evidence of an interaction effect between a SNP 
(rs13140176) in high LD with rs7697189 (r2 = 0.93) and sex on 
risk of COPD in UK Biobank25. This is likely in part to be due 
to reduced power to detect interaction effects on a binary trait. 
Indeed, in our study, the rs13140176-by-sex interaction effect on 
FEV
1
/FVC passes the conventional threshold for genome-wide 
significance (P<5×10-8) but when COPD was defined as FEV
1
/
FVC<0.7 this threshold was not met (P=0.023). Nevertheless, 
rs13140176 shows a consistent direction of effect between the 
studies: the lung function-lowering allele increases risk of COPD 
to a greater extent in males than females25.
The genome-wide significant sex interaction locus is located 
upstream of the HHIP gene, a region previously reported to 
be associated with lung function12,15 and HHIP gene expression19. 
The HHIP gene encodes hedgehog-interacting protein, a negative 
regulator of hedgehog signalling. The hedgehog signalling 
pathway regulates numerous physiological processes such as 
growth, self-renewal, cell survival, differentiation, migration, 
and tissue polarity and plays a vital role in the morphogenesis of 
lung and other organs26. Hedgehog signalling has also been 
shown to participate in regulation of stem and progenitor cell 
populations in adult tissues, impacting tissue homeostasis and 
repair27. SNP rs7697189, showing the strongest sex interaction 
on lung function in our study, is in strong linkage disequilibrium 
(R2 = 0.93) with SNPs residing in an HHIP enhancer region19. 
These enhancer-region SNPs were reported to be associated with 
enhancer activity and HHIP expression in lung tissues. They 
also exhibit genome-wide significant genotype-by-sex interac-
tions on lung function in our data. We therefore tested the effect 
of rs7697189 on HHIP expression in lung tissue from 472 males 
and 566 females to look for sex differential effects. In contrast 
to the previous study19, we found that the lung-function lowering 
G allele was associated with enhanced expression of HHIP in 
both males and females, and that expression was lower in males 
than females. However, the association between rs7697189 and 
HHIP expression was not modified by sex. This may be because 
there is no sex differential effect on expression, or the study 
might have been underpowered to detect an interaction effect. It 
is also possible that sex-differential effects of HHIP SNPs are 
only detectable in particular cell types. We therefore propose 
that HHIP eQTLs could be tested in larger numbers of males and 
females and in different cell types. Our in silico analyses predict 
that rs7697189 and a SNP in linkage disequilibrium (rs12504628) 
change transcription factor motifs that may be relevant to the 
effect of sex hormones on lung development, but experimental 
analyses will be required to test these hypotheses.
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Investigating the effects of HHIP at different stages of develop-
ment by sex may help to shed light on its mechanism of action. 
In our study we had access to genetic and lung function data 
from 5645 children with an average age of eight years. Though 
underpowered to detect the association between rs7697189 and 
FEV
1
 seen in UK Biobank adults, the lack of a similar trend in 
children suggests that HHIP variants may have differential 
effects at different developmental stages (though the genotype-by- 
sex interaction is in the same direction as in adults). We also 
looked for an effect of timing of puberty on the association 
between rs7697189 and lung function in adults, but adjustment for 
relative age of voice breaking in males and relative age at 
menarche in females made no difference to the relationship 
between rs7697189 and lung function. As UK Biobank participants 
were aged between 40 and 69 years at recruitment, we did not 
have the longitudinal data to investigate the effect of HHIP SNPs 
on trajectories of lung function decline throughout life28, but this 
could be an interesting area for future studies.
We identified four additional genome-wide significant (interaction 
P<5x10-8) sex-by-genotype interactions on lung function in our 
discovery analysis in UK Biobank, with a further 21 that met a 
less stringent threshold of interaction (P<1x10-6). As far as we are 
aware, this is the first genome-wide sex-by-genotype interaction 
study for lung function traits. We did not find a significant 
genotype-by-sex interaction on lung function or COPD at the 
CELSR1 locus (interaction P = 0.525 and P = 0.503, respectively) 
previously reported to have sex-specific effects on risk of COPD8.
In conclusion, we have identified a novel genotype-by-sex 
interaction at SNPs at a putative enhancer region upstream of 
the hedgehog-interacting protein (HHIP) gene. Establishing the 
mechanism by which HHIP has sex differential effects on 
lung function will be important for our understanding of the 
biological underpinnings of COPD in males and females. This 
knowledge, in turn, will be crucial to optimising treatment in 
males and females. 
Materials and Methods
Ethics and consent
This study used anonymised data from UK Biobank (RRID: SCR_
012815), which comprises over 500,000 volunteer participants 
aged 40–69 years recruited across Great Britain between 2006 
and 2010. The protocol and consent were approved by the 
UK Biobank’s Research Ethics Committee. Our analysis was 
conducted under approved UK Biobank data application number 
648. For SpiroMeta consortium cohorts, all participants provided 
written informed consent and studies were approved by local 
Research Ethics Committees and/or Institutional Review boards. 
Full ethics statements for each SpiroMeta consortium cohort is 
included in the S1 Appendix (Extended data,10).
UK Biobank
The UK Biobank is described here: http://www.ukbiobank.
ac.uk. Individuals were included in this study if (i) they had no 
missing data for sex, age, height, and smoking status, (ii) their 
spirometry data passed quality control, as described previously7, 
(iii) their genetically inferred sex matched their reported sex, 
(iv) they had genome-wide imputed genetic data, (v) they were 
of genetically determined European ancestry, and (vi) they 
were not first- or second-degree relatives of any other individual 
included in the study. In total, 303,612 individuals met these 
criteria (Table S2, Extended data10).
Participants’ DNA was genotyped using either the Affyme-
trix Axiom® UK BiLEVE array or the Affymetrix Axiom® UK 
Biobank array29. Genotypes were imputed based on the Human 
Reference Consortium (HRC) panel, as described elsewhere29. 
Variants with minor allele frequency (MAF)<0.01 were 
excluded, as were variants with imputation quality scores <0.3.
SpiroMeta consortium
The SpiroMeta consortium meta-analysis comprised 75,696 
individuals from 20 studies (see S1 Appendix for details, 
Extended data10). Ten studies (N=17,280) were imputed using 
1000 Genomes Phase 1 reference panel30,31, nine (N=37,919) 
were imputed using the Haplotype Reference Consortium (HRC) 
panel29, and one (N=2077) was imputed using the HapMap 
CEU Build 36 Release 22. The ALSPAC (RRID: SCR_007260) 
and Raine studies also provided data on children with an aver-
age age of eight years (N=4426 and N=1219, respectively). 
Tables S6 and S7 show definitions of all abbreviations, study 
characteristics, details of genotyping platforms and imputation 
panels and methods (Extended data10). Measurements of spirom-
etry for each study are as previously described7,21. Fourteen 
SpiroMeta studies had data on PEF (N=51,555).
Statistical analysis





and PEF were pre-adjusted for age, age2, standing height (or 
sitting height in the sensitivity analysis) and smoking status and 
the residuals rank-transformed to normality using the rntrans-
form function of the GenABEL package (RRID: SCR_001842) in 
R (RRID: SCR_001905). To test each imputed autosomal vari-
ant for an interaction effect, a linear regression model with gen-
otype (additive effect), sex, genotype-by-sex interaction, geno-
typing array and the first ten principal components included as 
covariates was implemented using Plink 2.0 software (RRID: 
SCR_001757). Step-wise conditional analyses to identify inde-
pendently associated variants were undertaken using GCTA 
software32,33.
Regression analysis to test genotype-by-sex interactions on height 
were conducted using a model including genotype (additive 
effect), age, age2, sex, genotyping array and the first ten principal 
components as covariates. Interactions between smoking status 
and genotype on lung function were tested using lung function 
traits transformed as described above (with sex included in the 
model instead of ever-smoking status). The linear regression 
model included genotype (additive effect), ever-smoking status, a 
genotype-by-smoking interaction term, genotyping array and the 
first ten principal components.
To test whether pubertal timing has differential effects on the 
association between SNPs and lung function in males and 
females, the regression model was adjusted for relative age at 
menarche in females and relative age at voice breaking in males. 
Relative age at voice breaking is categorised as earlier than 
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average (1), around average (2) and later than average (3) in 
UK Biobank. Age at menarche is given as the participant’s 
age at menarche in years. To make these variables comparable, 
age at menarche was categorised as early (<12 years old), average 
(12–14 years old) and late (>14 years old) as in a previous 
study34. As in the lung function analyses, ancestry-based prin-
cipal components and genotyping array were included in all the 
regression models.
For the SpiroMeta consortium, summary statistics were generated 
by each contributing cohort separately according to the same 
analysis plan as the UK Biobank data. Meta-analysis of SpiroMeta 
cohorts was conducted using inverse-variance weighted fixed 
effects meta-analysis using the metagen function of the meta 
package in R.
The lung eQTL study
The lung expression quantitative trait loci (eQTL) study database 
has been described previously35–37 and in S1 Appendix (Extended 
data10). HHIP differential gene expression analysis between 
females and males was performed using linear regression. Asso-
ciation of rs7697189 and rs7697189-by-sex interaction with 
gene expression was tested in 1,038 subjects with genotypes 
using MatrixEQTL package in R. All analyses were done 
separately in Laval, UBC and Groningen, and then combined 




UK Biobank data is an open access resource available to bona 
fide researchers undertaking health-related research. Researchers 
must apply for access (see https://www.ukbiobank.ac.uk/researchers/ 
for more details). Genome-wide interaction study summary 
statistics are available on Figshare (see below).
Figshare: Genome-wide sex interaction study summary statistics 
for lung function traits in UK Biobank. https://doi.org/10.6084/
m9.figshare.12298736.v138
Extended data
Figshare: Variants associated with HHIP expression have sex- 
differential effects on lung function: supplementary material. 
https://doi.org/10.6084/m9.figshare.1212920710
This project contains Fawcett_et_al_Extended_data_supplement.
docx, which contains the following extended data: 
•    Supplementary materials and methods
•    Figure S1. Genome-wide interaction SNP-by-sex inter-
action results on four measures of lung function in UK 
Biobank
•    Figure S2. Correlation between genotype-by-sex inter-
action effect sizes in UK Biobank and the SpiroMeta 
studies
•    Figure S3. Association between rs7697189 and FEV
1
 in 
children from the ALSPAC and Raine cohorts
•    Figure S4. GTEx data on expression of HHIP by sex in 
different tissues
•    Table S1. Association between rs7697189 and lung func-
tion traits in males and females, and genotype-by-sex 
interaction results
•    Table S2. UK Biobank demographics
•    Table S3. Sex-stratified association between rs7697189 
and lung function before and after adjustment for pubertal 
timing
•    Table S4. Association between rs7697189 and HHIP 
expression and rs7697189-by-sex interaction on HHIP 
expression
•    Table S5. Differential expression of HHIP in males 
compared to females
•    Table S6. SpiroMeta studies
•    Table S7. SpiroMeta analysis methods
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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The level of HHIP is known to be decreased in lung tissues from COPD patients. How could the 
results of this interaction study translate to the molecular pathogenesis of lung diseases eg. COPD 
vis-à-vis its prevalence in males and females at the study sites where samples were obtained? 
Again, the development of COPD is characterized by different stages. What is the relevance of the 
study to staging of lung diseases between males and females? 
 
Lung function partly reflects on the biological state of the organ and authors appear to propose 
that HHIP may exhibit sex differential effects on lung function. Could authors add a brief outlook 
for future experimental studies which may want to follow up on their findings? For example, are 
there differences in cell-specific expression of HHIP in the lungs of males and females and how 
can this relate to the pathogenesis and risk of lung diseases between the sexes?
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We are very grateful to the reviewer for taking the time to read and comment on our 
manuscript.  We will address the comments on a point-by-point basis: 
 
One key finding in this study was increased expression of (HHIP) in lung tissues from females 
compared to those from males. Authors should further explain or speculate possible reasons for 
this observation. 
 
The higher expression of HHIP in females is intriguing, but it is not clear (from our reading 
of the literature) why this might be. 
 
The level of HHIP is known to be decreased in lung tissues from COPD patients. How could the 
results of this interaction study translate to the molecular pathogenesis of lung diseases eg. 
COPD vis-à-vis its prevalence in males and females at the study sites where samples were 
obtained? Again, the development of COPD is characterized by different stages. What is the 
relevance of the study to staging of lung diseases between males and females? 
 
In our study, the lung-function-lowering allele of rs7697189 was associated with increased 
expression of HHIP.  This is the opposite direction of effect to that found in the Zhou et al. 
paper cited in the discussion, but is consistent with other reports (van der Plaat DA, de Jong 
K, Lahousse L, Faiz A, Vonk JM, van Diemen CC, Nedeljkovic I, Amin N, Brusselle GG, Hofman 
A, Brandsma CA, Bossé Y, Sin DD, Nickle DC, van Duijn CM, Postma DS, Boezen HM. 
Genome-wide association study on the FEV1/FVC ratio in never-smokers identifies HHIP and 
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obstructive pulmonary disease with lung eqtls.” PloS one vol. 8,7 e70220. 30 Jul. 2013, 
doi:10.1371/journal.pone.0070220) that show COPD risk alleles associated with increased 
HHIP expression .  It is possible that, given males have lower expression of HHIP than 
females, studies of COPD with a higher proportion of males amongst cases than controls 
could find spurious associations between lower HHIP expression and COPD. 
 
We assume that by "staging of lung diseases" the reviewer is referring to the different 
trajectories of COPD as outlined, for example, by Lange et al. (Lange P, Celli B, Agustí A, Boje 
Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, 
Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J. 
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J 
Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532. PMID: 26154786).  Without 
understanding the mechanism by which HHIP affects lung function, it is not clear how it 
would impact trajectories of lung disease.  In our discussion, we suggest longitudinal 
studies to test the effects of HHIP SNPs on trajectories of lung function decline in males and 
females. 
 
"As UK Biobank participants were aged between 40 and 69 years at recruitment, we did not 
have the longitudinal data to investigate the effect of HHIP SNPs on trajectories of lung 
function decline throughout life (28) , but this could be an interesting area for future 
studies." 
 
Lung function partly reflects on the biological state of the organ and authors appear to propose 
that HHIP may exhibit sex differential effects on lung function. Could authors add a brief outlook 
for future experimental studies which may want to follow up on their findings? For example, are 
there differences in cell-specific expression of HHIP in the lungs of males and females and how 
can this relate to the pathogenesis and risk of lung diseases between the sexes? 
 
We do suggest a number of possible avenues for follow up.  Though we find no interaction 
between HHIP SNPs and sex on HHIP expression, our sample size for the expression analysis 
was quite small.  Testing for interaction in larger datasets would therefore be warranted. 
 We also suggest investigating sex differential effects of HHIP at different developmental 
stages and on trajectories of lung function in longitudinal studies.  Finally, we propose 
testing our in silico-generated hypothesis that "rs7697189 and a SNP in linkage 
disequilibrium (rs12504628) change transcription factor motifs that may be relevant to the 
effect of sex hormones on lung development".  We are not aware of any cell-type specific 
datasets that would allow comparison of HHIP expression between males and females, but 
if these were available then they could indeed throw light on the mechanism of action of 
sex-differential effects of HHIP.  We have added the following to the discusssion: 
 
"It is also possible that sex-differential effects of HHIP SNPs are only detectable in particular 
cell types.  We therefore propose that HHIP eQTLs could be tested in larger numbers of 
males and females and in different cell types."  
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The authors provide an interesting analysis of the gene/sex interaction affect on lung function as 
demonstrated in the UK Biobank cohort and validated in the Spirometa consortium. They found a 
greater affect in males than females ( 28 mL vs 9 mL). 
 
Comments: The authors note that this gene is also related to height. Although they adjusted for 
standing height (and height squared) in the analysis they should note in the limitations that lung 
function is actually more closely related to sitting height (or even better- thoracic height) which is 
not well measured. Thus - it is possible that the difference could be explained by other factors 
related to how we estimate "normal" lung function.
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We would like to thank the reviewer for taking the time to review our manuscript.  We agree 
that sitting and thoracic height are more related to lung function than standing height and 
have therefore added the following to the discussion: 
 
"It should be noted, however, that lung function is more closely related to sitting and 
thoracic height than standing height.  We conducted sensitivity analyses showing that the 
rs7697189-by-sex interaction remained after adjustment for sitting height, but thoracic 
height was not available."  
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